Product Details
Palbociclib for Tablets BP
Product Name
:
Palbociclib for Tablets BP
Brand Name
:
VERPAL-C
Available Strength
:
125 mg
Packing
:
60 Tablets
Pack Insert/Leaflet
:
According To Your Needs
These film-coated tablets meet British Pharmacopoeia standards, supporting targeted treatment for hormone receptor-positive, HER2-negative breast cancer. Oncologists prescribe Palbociclib in combination with endocrine therapy for advanced or metastatic disease.
Palbociclib BP (125 mg) is a CDK4/6 inhibitor that blocks cell cycle progression in cancer cells, slowing tumor growth. As a result, it helps extend disease control when combined with hormone therapy. Because of this targeted mechanism, oncology specialists prescribe it under close supervision as part of a broader treatment regimen. Therefore, hospitals and oncology clinics restrict its use to patients under specialist care.
Key Features
- Meets BP (British Pharmacopoeia) standards for consistent quality
- Delivers targeted CDK4/6 inhibition for breast cancer therapy
- Ensures accurate, validated dosing in every batch
- Manufactured under GMP-compliant, high-alert medication handling protocols
- Intended strictly for use under oncologist supervision
- Restricted to hospital, oncology clinic, and specialist institutional supply